Oncolytic viruses as antigen-agnostic cancer vaccines

SJ Russell, GN Barber - Cancer cell, 2018 - cell.com
Selective destruction of neoplastic tissues by oncolytic viruses (OVs) leads to antigen-
agnostic boosting of neoantigen-specific cytotoxic T lymphocyte (CTL) responses, making …

Effector and memory T-cell differentiation: implications for vaccine development

SM Kaech, EJ Wherry, R Ahmed - Nature Reviews Immunology, 2002 - nature.com
Recent work shows that after stimulation with antigen, CD4+ and CD8+ T cells embark on a
programme of proliferation that is closely linked with the acquisition of effector functions and …

[HTML][HTML] Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity

S John, O Yuzhakov, A Woods, J Deterling, K Hassett… - Vaccine, 2018 - Elsevier
A cytomegalovirus (CMV) vaccine that is effective at preventing congenital infection and
reducing CMV disease in transplant patients remains a high priority as no approved …

Adoptive immunotherapy for cancer: building on success

L Gattinoni, DJ Powell Jr, SA Rosenberg… - Nature Reviews …, 2006 - nature.com
Adoptive cell transfer after host preconditioning by lymphodepletion represents an important
advance in cancer immunotherapy. Here, we describe how a lymphopaenic environment …

Functional significance of the perforin/granzyme cell death pathway

JA Trapani, MJ Smyth - Nature Reviews Immunology, 2002 - nature.com
Perforin/granzyme-induced apoptosis is the main pathway used by cytotoxic lymphocytes to
eliminate virus-infected or transformed cells. Studies in gene-disrupted mice indicate that …

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

KA Collins, R Snaith, MG Cottingham, SC Gilbert… - Scientific reports, 2017 - nature.com
The leading malaria vaccine in development is the circumsporozoite protein (CSP)-based
particle vaccine, RTS, S, which targets the pre-erythrocytic stage of Plasmodium falciparum …

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

L Gattinoni, SE Finkelstein, CA Klebanoff… - The Journal of …, 2005 - rupress.org
Depletion of immune elements before adoptive cell transfer (ACT) can dramatically improve
the antitumor efficacy of transferred CD8+ T cells, but the specific mechanisms that …

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

A Papadopoulou, U Gerdemann, UL Katari… - Science translational …, 2014 - science.org
It remains difficult to treat the multiplicity of distinct viral infections that afflict
immunocompromised patients. Adoptive transfer of virus-specific T cells (VSTs) can be safe …

Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy

CA Klebanoff, CD Scott, AJ Leonardi… - The Journal of …, 2016 - Am Soc Clin Investig
Adoptive cell transfer (ACT) of purified naive, stem cell memory, and central memory T cell
subsets results in superior persistence and antitumor immunity compared with ACT of …

CTLA-4: new insights into its biological function and use in tumor immunotherapy

JG Egen, MS Kuhns, JP Allison - Nature immunology, 2002 - nature.com
The discovery of multiple costimulatory cell surface molecules that influence the course of T
cell activation has increased our appreciation of the complexity of the T cell response. It …